PRNewswire

VALCOURT, QC, May 31, 2024 /PRNewswire/ - BRP Inc. (TSX: DOO) (NASDAQ: DOOO) (the "Company") held earlier today its annual meeting of shareholders in a virtual format. The meeting was broadcast via live webcast and the recording will be available shortly on BRP's website at www.brp.com.  

At the meeting, all of the nominees for directors listed in the... (continue reading...)

VANCOUVER, BC, May 31, 2024 /PRNewswire/ - Lumina Gold Corp. (TSXV: LUM) (OTCQB: LMGDF) (the "Company" or "Lumina") is pleased to announce that under the previously announced US$300 million precious metals purchase agreement (the "PMPA") with Wheaton Precious Metals International Ltd., a wholly owned subsidiary of Wheaton Precious Metals Corp. ("Wheaton"), the Company has drawn an additional installment of US$10.2 million. The draw consisted of two tranches, US$9... (continue reading...)

CHARLOTTE, N.C., May 31, 2024 /PRNewswire/ -- According to FARE, 33 million Americans, one in 10 adults and one in 13 children, are living with life-threatening food allergies. In response to escalating concerns over food allergens and cross-contact, Steritech, an industry leader in providing best-in-class food safety assessments and consulting services, is partnering with MenuTrinfo to provide the first-of-its-kind food allergy assessment to help better protect... (continue reading...)

Investigational chemotherapy-free regimen of RYBREVANT® plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease

Landmark Phase 3 MARIPOSA data featured in an oral presentation at ASCO 

CHICAGO, May 31, 2024 /PRNewswire/ -- Johnson & Johnson today announced new data from the Phase 3 MARIPOSA study demonstrating the benefit of first-line treatment with RYBREVANT® (amivantamab-vmjw) in combination with... (continue reading...)

PLYMOUTH MEETING, Pa., May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the "Inducement Plan").

The Compensation Committee of INOVIO's Board of Directors has approved the award of... (continue reading...)